With early treatment, people with HIV can expect a normal life expectancy and are not able to transmit the infection to other people. The treatment is daily antiretroviral therapy (ART), which stops the virus from replicating in the body.
Daily treatment requires daily good decision-making, which some find hard to manage. This can have serious clinical outcomes.
SHARE recognises the urgent need to develop new longer-acting injectable treatments that free patients from the burden of taking tablets daily and that could facilitate remission or cure.
Professor Chloe Orkin and Dr John Thornhill are leading this research theme.
To help bridge the gap between treatment and cure, SHARE is improving access to clinical research for people living with HIV in the parts of east London served by Barts Health. Our activities for this research theme include:
Go to Research Theme 2